Driving with Type 1 Diabetes: Real-World Evidence to Support Starting Glucose Level and Frequency of Monitoring During Journeys

There is limited evidence supporting the recommendation that drivers with insulin-treated diabetes need to start journeys with glucose >90 mg/dL. Glucose levels of drivers with type 1 diabetes were monitored for 3 weeks using masked continuous glucose monitoring (CGM).

Citation:
Trawley S, Stephens AN, McAuley SA, Speight J, ……. Davis EA, Holmes-Walker DJ, …….. Jones TW, O'Neal DN. Driving with Type 1 Diabetes: Real-World Evidence to Support Starting Glucose Level and Frequency of Monitoring During Journeys. Diabetes Technol Ther. 2022;24(5):350-6.

Keywords:
Blood glucose self-monitoring; Blood glucose/analysis; Driving; Road safety; Time in range; Type 1 diabetes

Abstract:
There is limited evidence supporting the recommendation that drivers with insulin-treated diabetes need to start journeys with glucose >90 mg/dL. Glucose levels of drivers with type 1 diabetes were monitored for 3 weeks using masked continuous glucose monitoring (CGM).